Wednesday, October 22, 2014 Last update: 5:03 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

The Best of U.S. Company Tech News - Updated Daily

Wednesday, October 26, 2011

  • Posted at 4:00 AM
    Today Biogen Idec (NASDAQ: BIIB) announced positive top-line results from CONFIRM, the second of two pivotal Phase 3 clinical trials designed to evaluate the investigational oral compound BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS). Results showed that ... read more
  • Posted at 4:00 AM
    SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 10/26/11 -- Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today announced that it met with the U.S. Food and Drug Administration (FDA) for a Pre-New Drug Application (Pre-NDA) meeting regarding Probuphine™, an innovative subcutaneous implant formulation of the marketed drug buprenorphine. Based upon this meeting, Titan believes that its Phase 3 clinical program completed to date is acceptable to the FDA to support submission of an NDA via the 505(b)(2) pathway and that ... read more
  • Posted at 4:00 AM
    SAN DIEGO, CA -- (Marketwire) -- 10/26/11 -- Cubic Applications, Inc. (CAI), a Mission Support Services subsidiary of Cubic Corporation (NYSE: CUB), has won four contracts worth a total of more than $10.8 million for continued training and support services at the U.S. Army's Combined Arms Center (CAC). The CAC, located at Fort Leavenworth, Kansas, provides Army-wide leadership and supervision for leader development and professional military and civilian education. The Center includes the Command and General Staff School (CGSS), ... read more
  • Posted at 3:44 AM
    Dr. Zein Obagi, MD, founder of ZO® Skin Health would like to announce that he is not affiliated with Obagi® Medical Products, Inc. in any business capacity. Likewise, Obagi® Medical Products does not sell any ZO® Skin Health product or endorse the views expressed by ZO® or Dr. Obagi as they relate to the use of Obagi Nu-Derm® or other Obagi® Medical products, or any other topics. Here's a helpful guide for consumers and media discussing ZO® and Obagi® Medical Products: ... read more
  • Posted at 3:30 AM
    Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three and nine months ended September 30, 2011. Financial Highlights -- Adjusted diluted EPS of $0.55 for the three months ended September 30 compared to $0.43 for the same prior year period; -- Adjusted diluted EPS of $1.51 for the nine months ended September 30 compared to $1.16 ... read more
  • Posted at 3:30 AM
    FRANKLIN LAKES, N.J., Oct. 26, 2011 /PRNewswire/ -- Third-Quarter 2011 Highlights: -- Record GAAP diluted earnings per share (EPS) of $0.90, or $0.96 when excluding $36.6 million of expenses associated with the pending Express Scripts merger, an increase of 12.9 percent over $0.85 in third-quarter 2010 -- Record diluted EPS, excluding all ... read more
  • CBIZ Reports Third Quarter 2011 Results --- CLEVELAND, Oct. 26, 2011
    Posted at 3:30 AM
    CBIZ, Inc. (NYSE: CBZ) today announced results for the third quarter ended September 30, 2011. CBIZ reported revenue of $177.1 million for the third quarter ended September 30, 2011, an increase of 0.7% over the $175.9 million recorded for the third quarter of 2010. Revenue from newly acquired operations, net of divestitures, contributed $4.8 million to revenue growth in the third quarter compared with the same period a year ago. Same-unit revenue decreased by 2.1%, or $3.6 ... read more
  • Posted at 3:26 AM
    Reportlinker.com announces that a new market research report is available in its catalogue: Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011 http://www.reportlinker.com/p0332346/Partnerships-Licensing-Investments-and-MA-Deals-and-Trends-in-Pharmaceuticals---October-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Investment_Banking Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011 Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership ... read more
  • Medical Imaging Markets: Contrast Agents --- NEW YORK, Oct. 26, 2011
    Posted at 3:24 AM
    Reportlinker.com announces that a new market research report is available in its catalogue: Medical Imaging Markets: Contrast Agents http://www.reportlinker.com/p0158569/Medical-Imaging-Markets-Contrast-Agents.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets. Since our last round-up of the contrast media market, the economic environment in the world has changed. Although the recession may ... read more
  • Posted at 3:20 AM
    Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its ECLIPSE 2 Hepatitis C Phase I/IIa multicenter study will be presented during a late breaker session at The ... read more
  • Posted at 3:18 AM
    On Saturday morning, October 22, 2011, The Tandem airship was launched from Nevada's Black Rock desert. The airship flew to 95,085 feet, higher than any airship in history. After fighting through extreme turbulence from 40,000 to 60,000 feet, Tandem soared to 95,085 feet. Tandem flew nearly four miles higher than any airship before. The pilot on the ground then remotely turned on the motors and flew the airship through a series of maneuvers. At the end of its mission one balloon ... read more
  • Posted at 3:18 AM
    Reportlinker.com announces that a new market research report is available in its catalogue: Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success http://www.reportlinker.com/p0119736/Early-Stage-Drug-Safety-Strategies-and-Risk-Management-Maximizing-opportunities-towards-achieving-clinical-success.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development Declining industrial productivity has forced companies to urgently address the areas of drug development that are most likely to lead to the failure of a new compound. Innovations are required that can support the earlier termination of drugs which will be toxic in humans and cause rare events that are unlikely to be identified in ... read more
  • World Advanced Electronic Packaging Market --- NEW YORK, Oct. 26, 2011
    Posted at 3:13 AM
    Reportlinker.com announces that a new market research report is available in its catalogue: World Advanced Electronic Packaging Market http://www.reportlinker.com/p098259/World-Advanced-Electronic-Packaging--Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Packaging This report analyzes the worldwide markets for Advanced Electronic Packaging in Millions of US$. The specific product segments analyzed are Ball Grid Arrays, Chip Scale Packages, and Multi Chip Modules. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles ... read more
  • Posted at 3:05 AM
    Aspera, Inc., creators of next-generation software technologies that move the world’s digital assets at maximum speed, today announced that Michelle Munson, CEO, president and co-founder is a featured speaker at the 2011 SMPTE Annual Technical Conference and Exhibition taking place ... read more
  • Drastic Changes in Recycling? --- SCOTTSDALE, Ariz.
    Posted at 3:05 AM
    On Oct. 29, 1991, Earth911 was founded by a man with a vision of creating a more sustainable world, right in his backyard. Originally starting off as a toll-free motor oil recycling information hotline for the Phoenix area, 1-800-CLEANUP(R) ... read more
  • Posted at 3:03 AM
    uSamp, one of the world’s fastest growing technology and online sampling companies, today introduced SurveyBuilder™ (www.surveybuilder.com), a self-serve platform providing free, unlimited online survey authoring tools that transforms the way organizations gain insights from target audiences and expands the market ... read more
  • Posted at 3:03 AM
    SEATTLE, WA -- (Marketwire) -- 10/26/11 -- Integrated Diagnostics, an emerging leader in molecular diagnostics, today announced that it has signed a worldwide licensing agreement with The Scripps Research Institute, strengthening its growing network of partners. Under the license, the company will have access to "click chemistry," a powerful chemical process developed by K. Barry Sharpless, Ph.D. Integrated Diagnostics concurrently announced that it has appointed Dr. Sharpless, who shared in the 2001 Nobel Prize for Chemistry, as an ... read more
  • Posted at 3:03 AM
    SEATTLE, WA -- (Marketwire) -- 10/26/11 -- Integrated Diagnostics, an emerging leader in molecular diagnostics, today announced that it has created a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. PCCs were created in collaboration with the California Institute of Technology (Caltech) using "click chemistry," a synthetic process that allows scientists to permanently join ("click") together molecular components with unusual precision and stability. PCCs offer the promise of superior stability, lower cost and faster ... read more
  • Posted at 3:00 AM
    Reportlinker.com announces that a new market research report is available in its catalogue: Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROI http://www.reportlinker.com/p0114851/Key-Trends-in-Offshoring-Pharmaceutical-RD-Company-strategies-emerging-markets-and-impact-on-ROI.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROIs Offshoring and outsourcing have become an increasingly critical contributor to pharma and biotech R&D strategies in recent years. They enable companies to focus on core competencies such as drug discovery or technology development whilst contracting out non-core processes to experts, often at ... read more
  • Posted at 3:00 AM
    ViaSat Inc. (Nasdaq: VSAT) has received approval from the Canadian Security Establishment Canada (CSEC) for use of its Eclypt® series of encrypted hard disk drives (HDD) to secure Government of Canada (GC) information up to and including Top Secret, as well as Canadian Eyes Only information. Canadian government organizations, already using Flagstone encryption products, can now use Eclypt HDD series to safeguard information at rest up to and including Top Secret knowing that they provide secure encryption. (Logo: http://photos.prnewswire.com/prnh/20091216/VIASATLOGO) The Canadian ... read more